-
Oncoscience AG announced a change in the board of directors
Oncoscience | October 15th, 2004
Oncoscience AG announced that Mrs. U. Bach, one of the founder, has left the board of directors for personnel reasons. T...
-
Oncoscience AG established scientific advisory board
Oncoscience | October 15th, 2004
Oncoscience AG is proud to inform about the establishment of the scientific advisory board with the first come together...
-
YM BioSciences’ EGFr antibody receives EU orphan drug designation through Oncoscience AG, its European partner
Oncoscience | August 10th, 2004
10.08.2004 – Mississauga. YM BioSciences Inc., the cancer drug development company with an advanced-stage portfolio, ...
-
Orphan-Drug-Designation finalised
Oncoscience | June 30th, 2004
Oncoscience AG announces that it finalised the Orphan-Drug-Designation for its monoclonal antibody h-R3 (Theraloc) with ...
-
AACR annual meeting 2004 – Late breaking news
Oncoscience | March 15th, 2004
Read the abstract “Establishing continuous single cell cultures from primary tumor excisions using a new generation of...
